Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03EEH
|
|||
| Former ID |
DIB001909
|
|||
| Drug Name |
Gadodiamide
|
|||
| Synonyms |
Omniscan; Gadodiamide hydrate; DV-7572; GdDTPA-BMA; S-041
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Central nervous system disease [ICD-11: 8A04-8D87; ICD-10: G00-G99] | Approved | [1], [2] | |
| Company |
GE Healthcare
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H26GdN5O8
|
|||
| Canonical SMILES |
CNC(=O)CN(CCN(CCN(CC(=O)NC)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]
|
|||
| InChI |
1S/C16H29N5O8.Gd/c1-17-12(22)7-20(10-15(26)27)5-3-19(9-14(24)25)4-6-21(11-16(28)29)8-13(23)18-2;/h3-11H2,1-2H3,(H,17,22)(H,18,23)(H,24,25)(H,26,27)(H,28,29);/q;+3/p-3
|
|||
| InChIKey |
HZHFFEYYPYZMNU-UHFFFAOYSA-K
|
|||
| CAS Number |
CAS 131410-48-5
|
|||
| PubChem Compound ID | ||||
| ADReCS Drug ID | BADD_D00985 ; BADD_D00986 | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | ClinicalTrials.gov (NCT00908310) Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.